Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 4, 2011, Pages 1095-1101

  Wang, Shu Lian ^a   Li, Ye Xiong ^a   Song, Yong Wen ^a   Wang, Wei Hu ^a   Jin, Jing ^a   Liu, Yue Ping ^a   Liu, Xin Fan ^a   Yu, Zi Hao ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Breast neoplasm; Estrogen receptor; Human epidermal growth factor 2; Progesterone receptor; Prognosis

Indexed keywords

BREAST NEOPLASM; ESTROGEN RECEPTOR; HUMAN EPIDERMAL GROWTH FACTOR; PROGESTERONE RECEPTOR; PROGNOSIS;

CHEMOTHERAPY; DISEASES; PATHOLOGY; PATIENT MONITORING; PEPTIDES;

PATIENT TREATMENT;

ANTHRACYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOFT TISSUE METASTASIS; TREATMENT DURATION; TREATMENT RESPONSE; VISCERAL METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79959354248     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.03.038     Document Type: Conference Paper

References (30)

1. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874 (Pubitemid 32878711)
2. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
3. T. Sorlie, R. Tibshirani, and J. Parker Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 2003 8418 8423 (Pubitemid 36842560)
4. H. Liu, Q. Fan, and Z. Zhang Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers Hum Pathol 39 2008 167 174
5. L.A. Carey, C.M. Perou, and C.A. Livasy Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502 (Pubitemid 43854964)
6. B.G. Haffty, Q. Yang, and M. Reiss Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657 (Pubitemid 46631305)
7. M.J. Kim, J.Y. Ro, and S.H. Ahn Clinicopathologic significance of the basal-like subtype of breast cancer: A comparison with hormone receptor and Her2/neu-overexpressing phenotypes Hum Pathol 37 2006 1217 1226 (Pubitemid 44286991)
8. P.L. Nguyen, A.G. Taghian, and M.S. Katz Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2008 2373 2378
9. G.M. Freedman, P.R. Anderson, and T. Li Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
10. M. Kyndi, F.B. Sorensen, and H. Knudsen Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426
11. S.E. Singletary, and J.L. Connolly Breast cancer staging: Working with the sixth edition of the AJCC Cancer Staging Manual CA Cancer J Clin 56 2006 37 47 quiz 50-31 (Pubitemid 43228386)
12. E.H. Romond, E.A. Perez, and J. Bryant Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684 (Pubitemid 41464706)
13. A. Recht, R. Gray, and N.E. Davidson Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group J Clin Oncol 17 1999 1689 1700 (Pubitemid 29269237)
14. A. Katz, E.A. Strom, and T.A. Buchholz Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation J Clin Oncol 18 2000 2817 2827 (Pubitemid 30623479)
15. A. Taghian, J.H. Jeong, and E. Mamounas Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials J Clin Oncol 22 2004 4247 4254 (Pubitemid 41185145)
16. J.A. van der Hage, H. Putter, and J. Bonnema Impact of locoregional treatment on the early-stage breast cancer patients: A retrospective analysis Eur J Cancer 39 2003 2192 2199 (Pubitemid 37297745)
17. M. Voordeckers, V. Vinh-Hung, and J. Lamote Survival benefit with radiation therapy in node-positive breast carcinoma patients Strahlenther Onkol 185 2009 656 662
18. M. Overgaard, P.S. Hansen, and J. Overgaard Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 337 1997 949 955 (Pubitemid 27425950)
19. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials Radiother Oncol 82 2007 247 253 (Pubitemid 46350797)
20. J. Ragaz, I.A. Olivotto, and J.J. Spinelli Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126 (Pubitemid 40277091)
21. F. Killander, H. Anderson, and S. Ryden Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - a randomized trial from the South Sweden Breast Cancer Group Breast 18 2009 309 315
22. K.R. Bauer, M. Brown, and R.D. Cress Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer Registry Cancer 109 2007 1721 1728 (Pubitemid 46668532)
23. M.C. Cheang, D. Voduc, and C. Bajdik Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 2008 1368 1376 (Pubitemid 351413917)
24. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: Clinical features and patterns of recurrence Clin Cancer Res 13 2007 4429 4434 (Pubitemid 47219710)
25. M. Tischkowitz, J.S. Brunet, and L.R. Begin Use of immunohistochemical markers can refine prognosis in triple negative breast cancer BMC Cancer 7 2007 134
26. R. Dent, W.M. Hanna, and M. Trudeau Pattern of metastatic spread in triple-negative breast cancer Breast Cancer Res Treat 115 2009 423 428
27. W.J. Yin, J.S. Lu, and G.H. Di Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients Breast Cancer Res Treat 115 2009 325 333
28. A.A. Luck, A.J. Evans, and A.R. Green The influence of basal phenotype on the metastatic pattern of breast cancer Clin Oncol (R Coll Radiol) 20 2008 40 45
29. L.G. Fulford, J.S. Reis-Filho, and K. Ryder Basal-like grade III invasive ductal carcinoma of the breast: Patterns of metastasis and long-term survival Breast Cancer Res 9 2007 R4
30. I.J. Dahabreh, H. Linardou, and F. Siannis Trastuzumab in the adjuvant treatment of early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials Oncologist 13 2008 620 630 (Pubitemid 351904907)